Tom 6, Nr 3 (2013)
Artykuł przeglądowy
Opublikowany online: 2013-10-11
Wyświetlenia strony
571
Wyświetlenia/pobrania artykułu
3392
Wybrane zagadnienia dotyczące antygenu D w świetle doniesień prezentowanych na 23. Zjeździe Międzynarodowego Towarzystwa Przetaczania Krwi w Amsterdamie
Journal of Transfusion Medicine 2013;6(3):105-108.
Streszczenie
Brak
Referencje
- Wagner F. RhesusBase v2: a versatile source of information on published RHD alleles. Vox Sang. 2013; 105(supl. 1): 1–64.
- Meshi A. Characterisation of antigenicity of an RhD peptide mimotope and assessment of its immunogenicity in HLA-DR15 transgenic mice. Vox Sang. 2013; 105(supl. 1): 1–64.
- Hall S, Hall M, Pickford J, et al. Combination peptide immunotherapy suppresses antibody and helper T cell responses to the RhD protein in HLA-transgenic mice. Vox Sang. 2013; 105(supl. 1): 65–299.
- Hall AM, Cairns LS, Altmann DM, et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood. 2005; 105(5): 2175–2179.
- Tan JC, Armstrong NJ, Yuan FF, et al. Genetic polymorphisms and immune response pathways associated with different responder profiles of RhD immunized blood donors. Vox Sang. 2013; 105(supl. 1): 1–64.
- Verduin EP, Schonewille H, Claas F, et al. HLA-DRB1*15 is a marker for multiple antibody responders. Vox Sang. 2013; 105(supl. 1): 1–64.
- Hong YJ, Chang HE, Hwang SM, et al. Molecular characteristics of partial D in Korea. Vox Sang. 2013; 105(supl. 1): 65–299.
- Silvy M, Granier T, Beley S, et al. First comprehensive investigation of both RHD and RHCE allele distribution in Sub-Saharan Africa: the clinical implications for transfusion medicine. Vox Sang. 2013; 105(supl. 1): 65–299.
- Hyland A, Gardener J, et al. O’Brien H. Managing diverse maternal RHD variants in alloimmunised and non-alloimmunised D negative pregnant women during fetal RHD genotyping. Vox Sang. 2013; 105(supl. 1): 1–64.
- Trucco Boggione C, Lujan Brajovich M, Tarrago M, et al. Molecular structures identified in serologically D negative samples of an admixed population. Vox Sang. 2013; 105(supl. 1): 1–64.
- Veldhuisen B, Thurik F, Jonkers R, et al. Molecular RHD variation of serological RhD negative women: implications for a fetal RHD screening programme to target anti-D prophylaxis. Vox Sang. 2013; 105(supl. 1): 1–64.
- Pisacka M, Sklenarova M, Kralova M, et al. VII: the most frequent partial D in Czech population with ‘Hidden Iceberg” real incidence: Results of a proficiency survey and D Variant Database in UHKT. Vox Sang. 2013; 105(supl. 1): 65–299.
- Figueiredo M, Chumakova A, Pereira J, et al. Being positive can be negative identification of a partial DIIIc. Vox Sang. 2013; 105(supl. 1): 65–299.
- Polin H, Ulrich S, Lanzer G, et al. RHD*WEAK D type 48 is prevalent in Southern Austria. Vox Sang. 2013; 105(supl. 1): 65–299.
- Castilho L, Machado D, Torres KB, et al. Jr. Anti-D in patients expressing weak D type 2. Vox Sang. 2013; 105(supl. 1): 65–299.
